Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review

M Goldfarb, M De Hert, J Detraux, K Di Palo… - Journal of the American …, 2022 - jacc.org
People with severe mental illness, consisting of schizophrenia, bipolar disorder, and major
depression, have a high burden of modifiable cardiovascular risk behaviors and conditions …

Psychosocial management in cardiac rehabilitation: current practices, recommendations, and opportunities

JW Hughes, ER Serber, T Kuhn - Progress in Cardiovascular Diseases, 2022 - Elsevier
Psychosocial management is a core component of outpatient Phase-II cardiac rehabilitation
(CR) and includes psychosocial assessment, providing interventions, measuring outcomes …

Depression and ischemic heart disease

CA Pivato, R Chandiramani, M Petrovic… - International Journal of …, 2022 - Elsevier
Depression is common in patients with ischemic heart disease, and depressed patients are
more likely to develop atherosclerosis and experience major cardiac events compared with …

Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized …

JA Blumenthal, PJ Smith, W Jiang, A Hinderliter… - American heart …, 2022 - Elsevier
Background Anxiety is a common comorbidity in patients with coronary heart disease (CHD)
and is associated with worse prognosis. However, effective treatment for anxiety in CHD …

Transdiagnostic cognitive-behavioral therapy for depression and anxiety disorders in cardiovascular disease patients: results from the CHAMPS pilot-feasibility trial

PJ Tully, DA Turnbull, JD Horowitz, JF Beltrame… - Frontiers in …, 2022 - frontiersin.org
Objective The aim of the Cardiovascular Health in Anxiety and Mood Problems Study
(CHAMPS) is to pilot the Unified Protocol (UP) for the transdiagnostic treatment of …

Management of psychiatric disorders in patients with cardiovascular diseases

PR Gundugurti, R Bhattacharyya… - Indian Journal of …, 2022 - journals.lww.com
In our clinical practice, we often see patients with physical disorders such as HTN or
coronary artery disease (CAD). There might be some significant drug-drug interactions …

Meta-analysis of antidepressant pharmacotherapy in patients eligible for cardiac rehabilitation: antidepressant ambivalence

JW Hughes, TA Kuhn, D Ede… - Journal of …, 2022 - journals.lww.com
Purpose: Many patients exhibit clinically significant depression upon enrollment in cardiac
rehabilitation (CR). Antidepressants are a first-line treatment option for depression, but the …

[HTML][HTML] Impact of depression on the quality of sleep and immune functions in patients with coronary artery disease

L Cai, L Wei, J Yao, Y Qin, Y You, L Xu, J Tang… - General …, 2022 - ncbi.nlm.nih.gov
Background The risk of major depressive disorder (MDD) and insomnia is higher in patients
with coronary heart disease (CHD) than in the general population. In addition, immune …

Safety considerations for prescribing SSRI antidepressants to patients at increased cardiovascular risk

JK Mortensen, G Andersen - Expert Opinion on Drug Safety, 2022 - Taylor & Francis
Introduction With the development of selective serotonin reuptake inhibitors (SSRI), a
relatively uncomplicated treatment of depression and a safer alternative to tricyclic …

[HTML][HTML] Depression interventions for individuals with coronary artery disease–cost-effectiveness calculations from an Irish perspective

SB Jabakhanji, J Sorensen, RM Carney… - Journal of …, 2022 - Elsevier
Background A substantial proportion of individuals with coronary artery disease experience
moderate or severe acute depression that requires treatment. We assessed the cost …